381
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Synthesis, antibacterial, photostability and molecular docking of novel push–pull dicyanomethylenedihydrofuran chromophores comprising antioxidant moieties

Article: 2297459 | Received 11 Sep 2023, Accepted 16 Dec 2023, Published online: 28 Dec 2023

Figures & data

Scheme 1. Synthesis of phenylvinyl-bridged dyes comprising hydroxylic substituents.

Scheme 1. Synthesis of phenylvinyl-bridged dyes comprising hydroxylic substituents.

Scheme 2. Synthesis of phenyl-bridged dye comprising 2° amine group.

Scheme 2. Synthesis of phenyl-bridged dye comprising 2° amine group.

Scheme 3. Synthesis of phenyl and phenylvinyl-bearing DCDHF dyes with a HTCX group.

Scheme 3. Synthesis of phenyl and phenylvinyl-bearing DCDHF dyes with a HTCX group.

Scheme 4. Synthesis of phenyl and phenylvinyl-bearing DCDHF dyes with a LSHA group.

Scheme 4. Synthesis of phenyl and phenylvinyl-bearing DCDHF dyes with a LSHA group.

Figure 1. Emission spectra of DCDHF fluorophores.

Figure 1. Emission spectra of DCDHF fluorophores.

Table 1. Photophysical parameters of DCDHF fluorophores.

Table 2. MIC results for the synthesized HTCX /LSHA-based hybrids.

Table 3. Binding energy (ΔG) and the percentage DHFR inhibition of the synthesized compounds against DHFR.

Table 4. In silico docking results of the prepared HTCX / LSHA-based fluorophores.

Figure 2. Docking images of HTCX -based hybrid 6 with 1LNZ.

Figure 2. Docking images of HTCX -based hybrid 6 with 1LNZ.

Figure 3. Docking images of HTCX -based hybrid DCDHF-7 with 1LNZ.

Figure 3. Docking images of HTCX -based hybrid DCDHF-7 with 1LNZ.

Figure 4. Docking images of HTCX -based hybrid DCDHF-8 with 1LNZ.

Figure 4. Docking images of HTCX -based hybrid DCDHF-8 with 1LNZ.

Figure 5. Docking images of LSHA-based hybrid DCDHF-15 with 1LNZ.

Figure 5. Docking images of LSHA-based hybrid DCDHF-15 with 1LNZ.

Figure 6. Docking images of LSHA-based hybrid DCDHF-16 with 1LNZ.

Figure 6. Docking images of LSHA-based hybrid DCDHF-16 with 1LNZ.

Figure 7. Docking images of Ampicillin with 1LNZ.

Figure 7. Docking images of Ampicillin with 1LNZ.

Figure 8. Docking images of HTCX -based hybrid 6 with 1AD4.

Figure 8. Docking images of HTCX -based hybrid 6 with 1AD4.

Figure 9. Docking images of HTCX -based hybrid 7 with 1AD4.

Figure 9. Docking images of HTCX -based hybrid 7 with 1AD4.

Figure 10. Docking images of HTCX -based hybrid 8 with 1AD4.

Figure 10. Docking images of HTCX -based hybrid 8 with 1AD4.

Figure 11. Docking images of HTCX -based hybrid 15 with 1AD4.

Figure 11. Docking images of HTCX -based hybrid 15 with 1AD4.

Figure 12. Docking images of HTCX -based hybrid 16 with 1AD4.

Figure 12. Docking images of HTCX -based hybrid 16 with 1AD4.

Figure 13. Docking images of HTCX -based hybrid Trimethoprim with 1AD4.

Figure 13. Docking images of HTCX -based hybrid Trimethoprim with 1AD4.

Table 5. In silico docking results of the prepared HTCX / LSHA-based against PDB: 1AD4.

Supplemental material

Supplemental Material

Download MS Word (2.2 MB)